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Letter to the Editor
With interest, we read the review article by Ahmadabadi et al. on autism 
spectrum disorders (ASDs) in inborn errors of metabolism (IEM) 
(1). They reviewed 37 studies, and found that IEMs underlie autistic 
features in <5% of the patients, and that there is growing evidence on 
the association between ASDs and mitochondrial disorders (MIDs), 
including mitochondrial encephalopathy, lactic acidosis, stroke-like 
episodes (MELAS) syndrome, and respiratory chain complex III/IV 
deficiency (1). The authors concluded that the syndromic autism, a 
strong family history, or consanguinity suggest IEM (1). However, we 
have raised the following comments and concerns:
We disagree with the idea that mitochondrial disorders (MIDs) have 
only two points of onset as they can occur at any age, and their 
broad variability, even in a family, results from the peculiarities of 
mitochondrial genetics. Due to mutations in mtDNA-located genes, 
MIDs are maternally transmitted, and the underlying mtDNA 
mutations may not occur in each mtDNA copy (heteroplasmy). 
Moreover, mtDNA copy number may considerably vary from one 
mitochondrion to another mitochondrion, particularly if the mutation 
is located in a nuclearly-encoded gene. MIDs frequently manifest in 
the central nervous system (CNS), and the CNS manifestations may 
include psychiatric or neurological diseases or both. The psychiatric 
diseases range from mild cognitive impairment and personality 
change to delirium and psychosis. Autism has been frequently 
reported in MIDs (2) and may or may not be associated with cerebral 
morphological alterations. 
We also disagree that ASD occurs only in MELAS and complex-III/
IV deficiency (1). ASD has also been reported in a patient carrying 
the mtDNA variant m.8363G>A, whose sister was carrying the same 
variant and presented with Leigh syndrome (3), as well as in two 
LETTER TO EDITOR
Autism spectrum disorder: A mitochondrial disorder
How to Cite This Article: Finsterer J . Autism spectrum disorder: A mitochondrial disorder. Iran J Child 
Neurol. Autumn 2021; 15(4): 115-117
Josef  FINSTERER MD1










Autism spectrum disorder: A mitochondrial disorder
Iran J Child Neurol. Autumn 2021 Vol. 15 No. 4
Korean siblings carrying the variant c.790C>T in 
TFB2M (4). In a study on 60 ASD patients, single 
mtDNA deletions were detected in 16.6% of the 
patients (5). In the same study, the ten patients with 
mtDNA deletions also carried single nucleotide 
variants (SNVs) in ASD-associated genes (5). In 
a study on 95 ASD patients, the mtDNA content 
decreased in the ASD patients, and 49 putative 
pathogenic mtDNA variants were detected (6). In 
a study on 10 families with ASD, whole-exome 
sequencing revealed the variants of interest (VOIs) 
in the ND5 gene in one family and VOIs in ATP6 
and NDUFS4 in another family (7). In a study 
on 24 Iranian ASD patients, mtDNA mutations 
16126T>C, m.14569G>A, and m.,1811A>G, all of 
which were located in non-coding regions, showed 
a significant relationship with ASD (8).
In general, there is ample evidence indicating 
that the IEM, which is most frequently associated 
with ASD, is MID. According to the literature, 
the mtDNA variants but not the nDNA variants 
have been more frequently associated with ASD. 
Patients with an ASD should be first examined in 
terms of the presence or absence of MID.
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